Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034 (Q41128589)

reason for preferred rank

27 September 2017

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034 (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

16 October 2022

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

16 October 2022

author name string

al-Sarraf M

3

1 reference

27 September 2017

G. E. Laramore

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

C. B. Scott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

M. al-Sarraf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

R. E. Haselow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

T. J. Ervin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

R. Wheeler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

J. R. Jacobs

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

D. E. Schuller

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

R. A. Gahbauer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

J. G. Schwade

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618662

16 October 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:036030169290642U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

https://api.elsevier.com/content/article/PII:036030169290642U?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

International Journal of Radiation Oncology Biology Physics

16 October 2022

published in

1 reference

27 September 2017

23

1 reference

27 September 2017

4

1 reference

27 September 2017

705-713

1 reference

27 September 2017

Cancer statistics, 1991.

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Adjuvant chemotherapy in head and neck cancer: promise vs. fulfillment

16 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry.

16 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program

16 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program

16 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

5-year results of cisplatin and fluorouracil infusion in head and neck cancer.

16 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Development of surgical quality-control mechanisms in large-scale prospective trials: head and neck intergroup report

16 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Nonparametric Estimation from Incomplete Observations

16 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group

16 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Evaluation of survival data and two new rank order statistics arising in its consideration

16 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group

16 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Analysis of treatment failure patterns. A Southwest Oncology Group Study

16 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Combined modality treatment with radiotherapy and chemotherapy

16 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

16 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90642-U

16 October 2022

Identifiers

0 references

1 reference